Abstract
To analyze the genomic differences between multiple myeloma (MM) and plasma cell leukemia (PCL), a total of 30 cases were studied by comparative genomic hybridization (CGH). In five cases with a low proportion of plasma cells (PC) in bone marrow, an enrichment of PC was performed by using immunomagnetic beads conjugated with the monoclonal antibody B-B4. In 24 out of the 25 MM (96%) and in all five PCL (100%) patients DNA copy number changes were identified by CGH analysis; in the MM case without chromosomal imbalances, the immunomagnetic enrichment of PC had failed. The most recurrent changes in MM patients were gains at chromosomes 15q (48%), 11q (44%), 3q (40%), 9q (40%) and 1q (36%). By contrast, all PCL patients showed gains in 1q. Losses of chromosomal material were significantly more frequent in PCL than in MM patients (P = 0.03): losses on 13q in 80% of PCL vs 28% of MM; and on chromosome 16 in 80% vs 12%, respectively. In addition, PCL patients showed losses of 2q and 6p that were not present in MM. The CGH data show differences in chromosomal imbalances between MM and PCL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Zandecki M, Lai JL, Facon T . Multiple myeloma: almost all patients are cytogenetically abnormal Br J Haematol 1996 94: 217–227
Brigaudeau C, Trimoreau F, Gachard N, Rouzier E, Jaccard A, Bordessoule D, Praloran V . Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method Br J Haematol 1997 96: 594–600
Facon T, Lai JL, Nataf E, Preudhomme C, Zandecki M, Hammad M, Wattel E, Jouet JP, Bauters F . Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients Br J Haematol 1993 84: 743–745
Smadja NV, Louvet C, Isnard F, Dutel JL, Grange MJ, Varette C, Krulik M . Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques Br J Haematol 1995 90: 619–624
Hernández JM, Gutiérrez NC, Almeida J, García JL, Sánchez MA, Mateo G, Ríos A, San Miguel JF . IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases Br J Haematol 1998 103: 163–167
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D . Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors Science 1992 258: 818–821
Avet-Loiseau H, Andree-Ashley LE, Moore D, Mellerin MP, Feusner J, Bataille R, Pallavicini MG . Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization Genes Chromos Cancer 1997 19: 124–133
Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michaeli J, Jhanwar SC, Chaganti RS . Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization Blood 1998 91: 3007–3010
Aalto Y, Nordling S, Kivioja AH, Karaharju E, Elomaa I, Knuutila S . Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma Genes Chromos Cancer 1999 25: 104–107
García-Sanz R, Orfao A, González M, Tabernero MD, Bladé J, Moro MJ, Fernández-Calvo J, Sanz MA, Pérez-Simón JA, Rasillo A, San Miguel JF . Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics Blood 1999 93: 1032–1037
Dimopoulos MA, Palumbo A, Delasalle KB, Alexanian R . Primary plasma cell leukaemia Br J Haematol 1994 88: 754–759
Chronic Leukemia-Myeloma Task Force NCI . Proposed guidelines for protocol studies: plasma cell myeloma Cancer Chemother Rep 1973 4: 145–158
Durie BGM, Salmon SE . A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 1975 36: 842–854
Avet-Loiseau H, Li JY, Facon T, Brigaudeau C, Morineau N, Maloisel F, Rapp MJ, Talmant P, Trimoreau F, Jaccard A, Harousseau JL, Bataille R . High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies Cancer Res 1998 58: 5640–5645
ISCN . Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature Karger: Basel 1995
Sambrook J, Fritsch EF, Maniatis T . Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor 1989
Lichter P, Bentz M, du Manoir S, Joos S . Comparative genomic hybridization. In: Vernon RS, Babu A (eds) Human Chromosomes. Principles and Techniques McGraw-Hill: New York 1995 pp 191–210
Beá S, Ribas M, Hernández JM, Bosch F, Pinyol M, Hernández L, García JL, Flores T, González M, López-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miró R, Campo E . Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants Blood 1999 93: 4365–4374
Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H, Knuutila S . Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma Genes Chromos Cancer 1998 21: 298–307
Knuutila S, Autio K, Aalto Y . Online access to CGH data of DNA sequence copy number changes Am J Pathol 2000 157: 689
Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G . Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation Genes Chromos Cancer 1999 25: 195–204
Brito-Babapulle V, Atkin NB . Break points in chromosome 1 abnormalities of 218 human neoplasms Cancer Genet Cytogenet 1981 4: 215–222
Johansson B, Mertens F, Mitelman F . Cytogenetic evolution patterns in non-Hodgkin's lymphoma Blood 1995 86: 3905–3914
Sawyer JR, Tricot G, Mattox S, Jagannath S, Barlogie B . Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin Blood 1998 91: 1732–1741
Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Solé F, Cuesta B, Gullón A . Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations Genes Chromos Cancer 1997 18: 84–93
Rao PH, Cigudosa JC, Ning Y, Calasanz MJ, Iida S, Tagawa S, Michaeli J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RS . Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma Blood 1998 92: 1743–1748
Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie B . Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping Blood 1998 92: 4269–4278
Chang H, Bouman D, Boerkoel CF, Stewart AK, Squire JA . Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization Leukemia 1999 13: 105–109
Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G . Deletion of the retinoblastoma gene in multiple myeloma Leukemia 1994 8: 1280–1285
Pérez-Simón JA, García-Sanz R, Tabernero MD, Almeida J, González M, Fernández-Calvo J, Moro MJ, Hernández JM, San Miguel JF, Orfao A . Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes Blood 1998 91: 3366–3371
Tricot G, Sawyer JR, Jagannath S, Desikan KR, Siegel D, Naucke S, Mattox S, Bracy D, Munshi N, Barlogie B . Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants J Clin Oncol 1997 15: 2659–2666
Bentz M, Dohner H, Huck K, Schutz B, Ganser A, Joos S, du Manoir S, Lichter P . Comparative genomic hybridization in the investigation of myeloid leukemias Genes Chromos Cancer 1995 12: 193–200
Persson K, Pandis N, Mertens F, Borg A, Baldetorp B, Killander D, Isola J . Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization Genes Chromos Cancer 1999 25: 115–122
Acknowledgements
This work was partially supported by grants from the Spanish FIS (97/1248; 98/1161 and 00/1089). The authors thank ME Fernández, P Fernández, MA Hernández and M Anderson for technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gutiérrez, N., Hernández, J., García, J. et al. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia 15, 840–845 (2001). https://doi.org/10.1038/sj.leu.2402116
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402116
Keywords
This article is cited by
-
Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background
Blood Cancer Journal (2019)
-
Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context
Molecular Cytogenetics (2014)
-
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Leukemia (2013)
-
POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17
Oncogene (2008)
-
Molecular biology of myeloma
Clinical and Translational Oncology (2007)